DRKS00017320
Not yet recruiting
未知
Development and evaluation of a digital symptom diary for supporting the self-management of multimorbid patients in GP's practices - TelePraCMan
niversitätsklinikum HeidelbergAbteilung Allgemeinmedizin und Versorgungsforschung0 sites200 target enrollmentJune 18, 2019
ConditionsMultimorbidity
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Multimorbidity
- Sponsor
- niversitätsklinikum HeidelbergAbteilung Allgemeinmedizin und Versorgungsforschung
- Enrollment
- 200
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Potential participants must be able to agree to participate in a study. In addition, all study participants must declare their informed consent to study participation and data analysation.
- •Special inclusion criteria according to study phases:
- •Feasibility study: Participating patients have to be part of the PraCMan\-programme have to have an iOS or Android smartphone/tablet. In Addition their consent to the terms of use of the digital symptom diary is a necessary prerequisite for participation.
- •Participating practices must have actively participated in PraCMan at least 6 months before the start of the TelePraCMan\-study.
- •Furthermore, they have to have at least 20 patients within the PraCMan\-programme. The use of PraCMan must be covered by a contract with AOK\-Baden\-Württemberg. The participating practices require at least one GP who is trained in using the PraCMan\-software and would like to participate voluntarily in the study, as well as at least one VERAH, who has been trained for PraCMan and is willing to participate actively in the project.
Exclusion Criteria
- •Persons who have no or only very limited skills in speaking German are excluded from study participation. Except in the case of expert panels and field research, persons who suffer from severe visual impairment or other physical or psychological circumstances (e.g. tremor, other serious illness), which hamper the use of a smartphone are also excluded from participation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effectiveness of Digital therapeutics in clinical symptoms of Attention Deficit/Hyperactivity DisorderMental and behavioural disordersKCT0007579CHUNGNAM NATIONAL UNIVERSITY SEJONG HOSPITA40
Terminated
Not Applicable
Development and Evaluation of A Digital Version of the REsilience Activities for every DaY (READY) Program for Adults with Multiple SclerosisMultiple SclerosisNeurological - Multiple sclerosisACTRN12621000602820niversity of Queensland56
Completed
Not Applicable
Investigation of the effectiveness of the digital intervention glykio for improving lifestyle and self-management in patients with type 2 diabetes mellitus (T2DM) after three months' useE11Type 2 diabetes mellitusDRKS00032134mementor DE GmbH76
Recruiting
Not Applicable
Investigating the effectiveness of the digital lifestyle intervention actensio to reduce blood pressure in adults with hypertension after six months of useI10Essential (primary) hypertensionDRKS00032452mementor DE GmbH422
Not yet recruiting
Not Applicable
Investigating the effect of the digital Patient Benefit Assessment Scale, a goals-based tool, on patient-centred outcomes in the healthcare process.caused by an insufficient supply of bloodintermittent claudicationpain and cramp in the calf muscles100232131002765610003216NL-OMON56868Medisch Spectrum Twente225